Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 63

PubMed for Gene (Select 10663)

1.

CXCR6: the role of environment in tumor progression. Challenges for therapy.

La Porta CA.

Stem Cell Rev. 2012 Dec;8(4):1282-5. doi: 10.1007/s12015-012-9383-6. Review.

PMID:
22678828
2.

Multiple-cohort genetic association study reveals CXCR6 as a new chemokine receptor involved in long-term nonprogression to AIDS.

Limou S, Coulonges C, Herbeck JT, van Manen D, An P, Le Clerc S, Delaneau O, Diop G, Taing L, Montes M, van't Wout AB, Gottlieb GS, Therwath A, Rouzioux C, Delfraissy JF, Lelièvre JD, Lévy Y, Hercberg S, Dina C, Phair J, Donfield S, Goedert JJ, Buchbinder S, Estaquier J, Schächter F, Gut I, Froguel P, Mullins JI, Schuitemaker H, Winkler C, Zagury JF.

J Infect Dis. 2010 Sep 15;202(6):908-15. doi: 10.1086/655782.

3.

Chemokine C-X-C motif receptor 6 contributes to cell migration during hypoxia.

Lin S, Sun L, Hu J, Wan S, Zhao R, Yuan S, Zhang L.

Cancer Lett. 2009 Jun 28;279(1):108-17. doi: 10.1016/j.canlet.2009.01.029. Epub 2009 Feb 23.

PMID:
19231068
4.

CXCR6 induces prostate cancer progression by the AKT/mammalian target of rapamycin signaling pathway.

Wang J, Lu Y, Wang J, Koch AE, Zhang J, Taichman RS.

Cancer Res. 2008 Dec 15;68(24):10367-76. doi: 10.1158/0008-5472.CAN-08-2780.

5.

CXCR6 identifies a putative population of retained human lung T cells characterised by co-expression of activation markers.

Morgan AJ, Guillen C, Symon FA, Birring SS, Campbell JJ, Wardlaw AJ.

Immunobiology. 2008;213(7):599-608. doi: 10.1016/j.imbio.2008.01.005. Epub 2008 Mar 7.

6.

CXCR6 is expressed in human prostate cancer in vivo and is involved in the in vitro invasion of PC3 and LNCap cells.

Hu W, Zhen X, Xiong B, Wang B, Zhang W, Zhou W.

Cancer Sci. 2008 Jul;99(7):1362-9. doi: 10.1111/j.1349-7006.2008.00833.x. Epub 2008 Apr 29. Erratum in: Cancer Sci. 2008 Dec;99(12):2548.

PMID:
18452560
7.

TLR4-NOX4-AP-1 signaling mediates lipopolysaccharide-induced CXCR6 expression in human aortic smooth muscle cells.

Patel DN, Bailey SR, Gresham JK, Schuchman DB, Shelhamer JH, Goldstein BJ, Foxwell BM, Stemerman MB, Maranchie JK, Valente AJ, Mummidi S, Chandrasekar B.

Biochem Biophys Res Commun. 2006 Sep 8;347(4):1113-20. Epub 2006 Jul 13.

PMID:
16870145
8.

CXCR6 within T-helper (Th) and T-cytotoxic (Tc) type 1 lymphocytes in Graves' disease (GD).

Aust G, Kamprad M, Lamesch P, Schmücking E.

Eur J Endocrinol. 2005 Apr;152(4):635-43.

9.

Expression of chemokine receptor CXCR6 in human colorectal adenocarcinomas.

Wågsäter D, Dimberg J.

Anticancer Res. 2004 Nov-Dec;24(6):3711-4.

10.

Down-regulation of cell surface CXCR6 expression during T cell activation is predominantly mediated by calcineurin.

Koprak S, Matheravidathu S, Springer M, Gould S, Dumont FJ.

Cell Immunol. 2003 May;223(1):1-12.

PMID:
12914753
11.

Genetic influence of CXCR6 chemokine receptor alleles on PCP-mediated AIDS progression among African Americans.

Duggal P, An P, Beaty TH, Strathdee SA, Farzadegan H, Markham RB, Johnson L, O'Brien SJ, Vlahov D, Winkler CA.

Genes Immun. 2003 Jun;4(4):245-50.

PMID:
12761559
12.

Chemokine receptor expression on MBP-reactive T cells: CXCR6 is a marker of IFNgamma-producing effector cells.

Calabresi PA, Yun SH, Allie R, Whartenby KA.

J Neuroimmunol. 2002 Jun;127(1-2):96-105.

PMID:
12044980
13.

The immunodeficiency virus coreceptor, Bonzo/STRL33/TYMSTR, is expressed by macaque and human skin- and blood-derived dendritic cells.

Ignatius R, Wei Y, Beaulieu S, Gettie A, Steinman RM, Pope M, Mojsov S.

AIDS Res Hum Retroviruses. 2000 Jul 20;16(11):1055-9.

PMID:
10933620
14.

TYMSTR, a putative chemokine receptor selectively expressed in activated T cells, exhibits HIV-1 coreceptor function.

Loetscher M, Amara A, Oberlin E, Brass N, Legler D, Loetscher P, D'Apuzzo M, Meese E, Rousset D, Virelizier JL, Baggiolini M, Arenzana-Seisdedos F, Moser B.

Curr Biol. 1997 Sep 1;7(9):652-60.

15.

Blockade of the CXCR6 signaling inhibits growth and invasion of hepatocellular carcinoma cells through inhibition of the VEGF expression.

Xu JM, Weng MZ, Song FB, Chen JY, Zhang JY, Wu JY, Qin J, Jin T, Wang XL.

Int J Immunopathol Pharmacol. 2014 Oct-Dec;27(4):553-61.

PMID:
25572735
16.

CXCL16 and CXCR6 in Ewing sarcoma family tumor.

Na KY, Kim HS, Jung WW, Sung JY, Kalil RK, Kim YW, Park YK.

Hum Pathol. 2014 Apr;45(4):753-60. doi: 10.1016/j.humpath.2013.09.017. Epub 2013 Nov 21.

PMID:
24507753
17.

Plasmacytoid dendritic cell response to CpG ODN correlates with CXCL16 expression and is inhibited by ox-LDL.

Gursel M, Klinman DM, Gursel I.

Mediators Inflamm. 2013;2013:312590. doi: 10.1155/2013/312590. Epub 2013 Nov 4.

18.

The CXCL16-CXCR6 chemokine axis in glial tumors.

Hattermann K, Held-Feindt J, Ludwig A, Mentlein R.

J Neuroimmunol. 2013 Jul 15;260(1-2):47-54. doi: 10.1016/j.jneuroim.2013.04.006. Epub 2013 Apr 28.

PMID:
23628207
19.

Associations of CXCL16/CXCR6 with carotid atherosclerosis in patients with metabolic syndrome.

Lv Y, Hou X, Ti Y, Bu P.

Clin Nutr. 2013 Oct;32(5):849-54. doi: 10.1016/j.clnu.2013.01.008. Epub 2013 Jan 23.

PMID:
23398954
20.

CXCL16 and CXCR6 are upregulated in psoriasis and mediate cutaneous recruitment of human CD8+ T cells.

Günther C, Carballido-Perrig N, Kaesler S, Carballido JM, Biedermann T.

J Invest Dermatol. 2012 Mar;132(3 Pt 1):626-34. doi: 10.1038/jid.2011.371. Epub 2011 Nov 24.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk